MET and ERBB2 are coexpressed in ERBB2+ breast cancer and contribute to innate resistance (Q39130764)

From Wikidata
Jump to navigation Jump to search
scientific article published on 3 July 2013
edit
Language Label Description Also known as
English
MET and ERBB2 are coexpressed in ERBB2+ breast cancer and contribute to innate resistance
scientific article published on 3 July 2013

    Statements

    MET and ERBB2 are coexpressed in ERBB2+ breast cancer and contribute to innate resistance (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit